Clene Inc. — Director's Dealing 2021

Apr 13, 2021

SEC Form 3/A — Form 3/A

Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2020-12-30

Reporting Person: Glanzman Robert (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$2.50		Common Stock (290351.00)		Direct

Footnotes

F1: This Form 3 amendment is being filed to correct an error in the original Form 3 filed on January 4, 2021 to reflect a correction in the exercise price that resulted from an internal calculation error.

F2: Awarded under the Clene Nanomedicine, Inc. 2014 Stock Plan on August 26, 2019 and currently exercisable. The options expire 10 years from the date of the grant.